Comparison of intubating conditions with propofol- suxamethonium versus propofol-lidocaine in pediatric patients aged 3 – 16 years old undergoing elective surgery: A randomized, double-blinded controlled trial
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Abstract
Introduction: Suxamethonium, a depolarizing muscle relaxant, offers rapid onset and optimal
intubating conditions. However, due to its adverse effects, researchers have sought safer
alternatives. Propofol alone provides adequate but suboptimal intubation conditions, while studies
suggest that combining intravenous lidocaine with propofol may improve outcomes. Therefor; this
study aims to compared tracheal intubation conditions and ease between two regimens: propofol
with suxamethonium (PS) versus propofol-lidocaine (PL).
Materials and Methods: A prospective, randomized, double-blinded controlled trial was
performed after ethical approval from the St. Paul Specialized Hospital institutional review board
(IRB). Ninety-two eligible patients (aged 3 - 16 years) was randomized into PS (2 mg/kg propofol
+ 1.5 mg/kg suxamethonium) or PL (2 mg/kg propofol + 1.5 mg/kg IV lidocaine) groups.
Intubating conditions were assessed using a 0–6 scale evaluating jaw relaxation, intubation ease,
and reflex response. Scores were categorized as: Good (5–6), Moderate (3–4), and Poor (0–2).
Results: this study revealed that 95.7% of the patients in the PS group achieved good intubating
conditions and 100% successful intubation. In contrast, the PL group demonstrated moderate
intubating conditions in 56.5% and poor conditions in 43.5% of patients. The overall intubation
success rate in the PL group was 73.9%, with a 26.1% failure rate.
Conclusion: Although propofol and lidocaine can facilitate laryngoscopy and tracheal intubation
without suxamethonium, the combination is associated with a significantly lower success rate and
less favorable intubating conditions compared to propofol-suxamethonium.
Keywords: Endotracheal intubation, Propofol, Lidocaine, Suxamethonium, Opioids, Ethiopia